536565 — Novelix Pharmaceuticals Balance Sheet
0.000.00%
- IN₹1.91bn
- IN₹1.83bn
- IN₹1.32bn
Annual balance sheet for Novelix Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 26 | 27.7 | 1.18 | 6.79 | 128 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11.9 | 2.68 | 0.134 | 252 | 590 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 46.3 | 42.4 | 41.3 | 269 | 889 |
| Net Property, Plant And Equipment | 2.26 | 1.74 | 1.18 | 1.86 | 15.2 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 72.5 | 72.6 | 73.6 | 272 | 924 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.082 | 0.616 | 0.101 | 96.7 | 416 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.082 | 0.616 | 0.101 | 96.7 | 459 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 72.4 | 72 | 73.5 | 175 | 465 |
| Total Liabilities & Shareholders' Equity | 72.5 | 72.6 | 73.6 | 272 | 924 |
| Total Common Shares Outstanding |